Abstract
A combination of ligand–receptor interactions and drug-like indexes have been used to develop a quantitative structure–activity relationship model to predict anti-HIV activity (pEC50) of 73 azine derivatives as non-nucleoside reverse transcriptase inhibitors. Ligand–receptor interactions were derived from the best position (best pose) of studied compounds, as ligands, in the active site of receptors using Autodock 4.2 software and named as molecular docking descriptors. The drug-like indexes were calculated using DRAGON 5.5 software. Two groups of descriptors were mixed, and the stepwise regression method was used for the selection of the most relevant descriptors. Four selected descriptors were subsequently used to construct the quantitative structure–activity relationship model using the Levenberg–Marquardt artificial neural network method. Dataset was randomly divided into the train (53 compounds), validation (10 compounds) and test set (10 compounds). The best model was selected according to the lowest mean square error value of the validation set. The accuracy and predictability of the model were evaluated using test and validation sets and the leave-one-out technique. According to the predicted results, the coefficient of determination of the test set (R2 = 0.86) and all data (\({Q}_{LOO}^{2}\)= 0.73) were acceptable. The mean square error value for the test set was equal to 0.11. The obtained results emphasized the good prediction ability and generalizability of the developed model in the prediction of pEC50 values for new compounds.
Similar content being viewed by others
Data availability
The datasets analyzed during the current study are available from the corresponding author on reasonable request.
References
Amini Z, Fatemi MH, Gharaghani S (2016) Hybrid docking-QSAR studies of DPP-IV inhibition activities of a series of aminomethyl-piperidones. Comput Biol Chem 64:335–345. https://doi.org/10.1016/j.compbiolchem.2016.08.003
Arab Chamjangali M (2009) Modelling of cytotoxicity data (CC50) of anti-HIV 1-[5-Chlorophenyl) Sulfonyl]-1H-pyrrole derivatives using calculated molecular descriptors and levenberg–marquardt artificial neural network. Chem Biol Drug Des 73:456–465. https://doi.org/10.1111/j.1747-0285.2009.00790.x
Arab Chamjangali M, Ashrafi M (2013) QSAR study of necroptosis inhibitory activities (EC 50) of [1, 2, 3] thiadiazole and thiophene derivatives using Bayesian regularized artificial neural network and calculated descriptors. Med Chem Res 22:392–400. https://doi.org/10.1007/s00044-012-0027-9
Arab Chamjangali M, Beglari M, Bagherian G (2007) Prediction of cytotoxicity data (CC50) of anti-HIV 5-pheny-l-phenylamino-1H-imidazole derivatives by artificial neural network trained with Levenberg–Marquardt algorithm. J Mol Graphics Model 26:360–367. https://doi.org/10.1016/j.compbiolchem.2019.107113
Arab Chamjangali M, Mohammadrezaei M, Kalantar Z, Amin AH (2012) Bayesian regularized artificial neural network modeling of the anti-protozoal activities of 1-methylbenzimidazole derivatives against T. Vaginalis infection. J Chin Chem Soc 59:743–752. https://doi.org/10.1002/jccs.201100417
Asadollahi-Baboli M (2016) In silico evaluation, molecular docking and QSAR analysis of quinazoline-based EGFR-T790M inhibitors. Mol Divers 20:729–739
Awale M, Kumar V, Saravanan P, Mohan CG (2010) Homology modeling and atomic level binding study of Leishmania MAPK with inhibitors. J Mol Model 16:475–488. https://doi.org/10.1007/s00894-009-0565-3
Beglari M, Goudarzi N, Shahsavani D, Chamjangali MA, Mozafari Z (2020) Combination of radial distribution functions as structural descriptors with ligand-receptor interaction information in the QSAR study of some 4-anilinoquinazoline derivatives as potent EGFR inhibitors. Struct Chem 2:1–11
Berman H et al (2000) The protein data Bank. Nucleic Acids Res 28:235–242. https://doi.org/10.1093/nar/28.1.235
Chakraborty S, Ramachandran B, Basu S (2014) Encompassing receptor flexibility in virtual screening using ensemble docking-based hybrid QSAR: discovery of novel phytochemicals for BACE1 inhibition. Mol Biosyst 10:2684–2692. https://doi.org/10.1039/C4MB00307A
Chen C-P, Chen C-C, Huang C-W, Chang Y-C (2018) Evaluating molecular properties involved in transport of small molecules in stratum corneum: a quantitative structure-activity relationship for skin permeability. Molecules 23:911. https://doi.org/10.3390/molecules23040911
Chen L, Chen X (2012) Results of molecular docking as descriptors to predict human serum albumin binding affinity. J Mol Graphics Model 33:35–43. https://doi.org/10.1016/j.jmgm.2011.11.003
Chen W et al (2014) Discovery of 2-pyridone derivatives as potent HIV-1 NNRTIs using molecular hybridization based on crystallographic overlays. Biorg Med Chem 22:1863–1872. https://doi.org/10.1016/j.bmc.2014.01.054
Chen X et al (2013) Novel piperidinylamino-diarylpyrimidine derivatives with dual structural conformations as potent HIV-1 non-nucleoside reverse transcriptase inhibitors. Bioorg Med Chem Lett 23:6593–6597. https://doi.org/10.1016/j.bmcl.2013.10.059
Chen X et al (2012) Design, synthesis, anti-HIV evaluation and molecular modeling of piperidine-linked amino-triazine derivatives as potent non-nucleoside reverse transcriptase inhibitors. Biorg Med Chem 20:3856–3864. https://doi.org/10.1016/j.bmc.2012.04.030
Cherqaoui D, Villemin D (1994) Use of a neural network to determine the boiling point of alkanes. J Chem Soc Faraday Trans 90:97–102
Coi A, Bianucci AM (2013) Combining structure-and ligand-based approaches for studies of interactions between different conformations of the hERG K+ channel pore and known ligands. J Mol Graphics Model 46:93–104
Davood A, Iman M (2011) Docking and QSAR studies of β-phenylethylidenehydrazine derivatives as a Gamma-aminobutyric acid aminotransferase inhibitor. Med Chem Res 20:955–961. https://doi.org/10.1007/s00044-010-9423-1
Ebrahimi M, Khayamian T (2014) Interactions of G-quadruplex DNA binding site with berberine derivatives and construct a structure-based QSAR using docking descriptors. Med Chem Res 23:1327–1339. https://doi.org/10.1007/s00044-013-0733-y
Ebrahimi M, Khayamian T, Gharaghani S (2012) Interactions between activin-like Kinase 5 (ALK5) receptor and its inhibitors and the construction of a docking descriptor-based QSAR model. J Braz Chem Soc 23:2043–2092. https://doi.org/10.1590/S0103-50532012005000082
Fatemi MH, Heidari A, Gharaghani S (2015) QSAR prediction of HIV-1 protease inhibitory activities using docking derived molecular descriptors. J Theor Biol 369:13–22. https://doi.org/10.1016/j.jtbi.2015.01.008
Feinstein WP, Brylinski M (2015) Calculating an optimal box size for ligand docking and virtual screening against experimental and predicted binding pockets. J Cheminform 7:18. https://doi.org/10.1186/s13321-015-0067-5
Garg A, Tewari R, Raghava GP (2010) K i DoQ: using docking based energy scores to develop ligand based model for predicting antibacterials. BMC Bioinform 11:125. https://doi.org/10.1186/1471-2105-11-125
Gharaghani S, Khayamian T, Ebrahimi M (2013) Molecular dynamics simulation study and molecular docking descriptors in structure-based QSAR on acetylcholinesterase (AChE) inhibitors SAR QSAR. Environ Res 24:773–794. https://doi.org/10.1080/1062936X.2013.792877
Ghose AK, Viswanadhan VN, Wendoloski JJ (1999) A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J Comb Chem 1:55–68. https://doi.org/10.1021/cc9800071
Golbraikh A, Tropsha A (2002) Beware of q2! J Mol Graphics Model 20:269–276. https://doi.org/10.1016/S1093-3263(01)00123-1
Goodsell DS, Morris GM, Olson AJ (1996) Automated docking of flexible ligands: applications of AutoDock. J Mol Recognit 9:1–5. https://doi.org/10.1002/(SICI)1099-1352(199601)9:1<1:AID-JMR241>3.0.CO;2-6
Gramatica P, Sangion A (2016) A historical excursus on the statistical validation parameters for QSAR models: a clarification concerning metrics and terminology. J Chem Inf Model 56:1127–1131. https://doi.org/10.1021/acs.jcim.6b00088
Hyperchem (2002) Hyperchem 8.0.5 Hypercube, USA
Khajeh A, Modarress H (2014) Linear and nonlinear quantitative structure-property relationship modelling of skin permeability. SAR QSAR Environ Res 25:35–50. https://doi.org/10.1080/1062936X.2013.826275
Kramer B, Rarey M, Lengauer T (1999) Evaluation of the FLEXX incremental construction algorithm for protein–ligand docking proteins. Struct Funct Bioinf 37:228–241. https://doi.org/10.1002/(SICI)1097-0134(19991101)37:2<228:AID-PROT8>3.0.CO;2-8
Leelananda SP, Lindert S (2016) Computational methods in drug discovery. Beilstein J Org Chem 12:2694–2718. https://doi.org/10.3762/bjoc.12.267
Li D, Zhan P, Liu H, Pannecouque C, Balzarini J, De Clercq E, Liu X (2013) Synthesis and biological evaluation of pyridazine derivatives as novel HIV-1 NNRTIs. Biorg Med Chem 21:2128–2134. https://doi.org/10.1016/j.bmc.2012.12.049
MacDougall IJ, Griffith R (2006) Selective pharmacophore design for α1-adrenoceptor subtypes. J Mol Graphics Model 25:146–157. https://doi.org/10.1016/j.jmgm.2005.12.001
MATLAB (2015) R2015a. https://www.mathworks.com/,
Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 19:1639–1662. https://doi.org/10.1002/(SICI)1096-987X(19981115)19:14<1639:AID-JCC10>3.0.CO;2-B
Muhammad U, Uzairu A, Ebuka Arthur D (2018) Review on: quantitative structure activity relationship (QSAR) modeling. J Anal Pharm Res 7:2
Ojha Lokendra K, Rachana S, Rani BM (2013) Modern drug design with advancement in QSAR: a review. Int J Res Biosci 2:1–12
Pham-The H, Le-Thi-Thu H (2018) Integrating structure and ligand-based approaches for modelling the histone deacetylase inhibition activity of hydroxamic acid derivatives. Asian J Pharm Clin Res 11:198–206 https://doi.org/10.22159/ajpcr.2018.v11i2.22995
Quesada-Romero L, Caballero J (2014) Docking and quantitative structure–activity relationship of oxadiazole derivates as inhibitors of GSK3β. Mol Divers 18:149–159. https://doi.org/10.1007/s11030-013-9483-5
Rasouli Y, Davood A (2018) Hybrid Docking-QSAR studies of 1, 4-dihydropyridine-3, 5-dicarboxamides as potential antitubercular agents. Curr Comput Aided Drug Des 14:35–53. https://doi.org/10.2174/1573409913666170426154045
Safarizadeh H, Garkani-Nejad Z (2019) Molecular docking, molecular dynamics simulations and QSAR studies on some of 2-arylethenylquinoline derivatives for inhibition of Alzheimer's amyloid-beta aggregation: Insight into mechanism of interactions and parameters for design of new inhibitors. J Mol Graphics Model 87:129–143. https://doi.org/10.1016/j.jmgm.2018.11.019
Santos LH, Ferreira RS, Caffarena ER (2015) Computational drug design strategies applied to the modelling of human immunodeficiency virus-1 reverse transcriptase inhibitors. Mem Inst Oswaldo Cruz 110:847–864. https://doi.org/10.1590/0074-02760150239
Sheikhpour R, Sarram MA, Gharaghani S (2017) Constraint score for semi-supervised feature selection in ligand-and receptor-based QSAR on serine/threonine-protein kinase PLK3 inhibitors. Chemometr Intellig Lab Syst 163:31–40. https://doi.org/10.1016/j.chemolab.2017.02.006
Singla D, Anurag M, Dash D, Raghava GP (2011) A web server for predicting inhibitors against bacterial target GlmU protein. BMC Pharmacol 11:5. https://doi.org/10.1186/1471-2210-11-5
Todeschini R, Consonni V, Mauri A, Pavan M (2008) DRAGON 5.5 for Windows Talete srl, Milan, Italy
Toor JS, Sharma A, Kumar R, Gupta P, Garg P, Arora SK (2011) Prediction of drug-resistance in HIV-1 subtype C based on protease sequences from ART naive and first-line treatment failures in North India using genotypic and docking analysis. Antiviral Res 92:213–218. https://doi.org/10.1016/j.antiviral.2011.08.005
Tropsha A, Gramatica P, Gombar VK (2003) The importance of being earnest: validation is the absolute essential for successful application and interpretation of QSPR models. QSAR Comb Sci 22:69–77. https://doi.org/10.1002/qsar.200390007
ViewerLite (1998) version 5.0 vol 9685. https://www.3dsbiovia.com,
Wang J, Zhan P, Li Z, Liu H, De Clercq E, Pannecouque C, Liu X (2014) Discovery of nitropyridine derivatives as potent HIV-1 non-nucleoside reverse transcriptase inhibitors via a structure-based core refining approach. Eur J Med Chem 76:531–538. https://doi.org/10.1016/j.ejmech.2014.02.047
Zhang X (2018) Anti-retroviral drugs: current state and development in the next decade. Acta Pharm Sin B 8:131–136. https://doi.org/10.1016/j.apsb.2018.01.012
Zheng F, Zhan M, Huang X, Hameed MDMA, Zhan C-G (2014) Modeling in vitro inhibition of butyrylcholinesterase using molecular docking, multi-linear regression and artificial neural network approaches. Biorg Med Chem 22:538–549. https://doi.org/10.1016/j.bmc.2013.10.053
Zhou Q, Zhang N, Zhang C, Huang L, Niu Y, Zhang Y, Liu W (2010) Molecular mechanism of enantioselective inhibition of acetolactate synthase by imazethapyr enantiomers. J Agric Food Chem 58:4202–4206. https://doi.org/10.1021/jf9038953
Acknowledgments
The authors are thankful to the Shahrood University of Technology Research Council for supporting this work.
Author information
Authors and Affiliations
Contributions
MB: conceptualization, methodology, validation, writing original, draft, writing-review, visualization. NG: supervision, project administration, editing. DS: software, validation, methodology. MAC: conceptualization, investigation, writing-editing. ZM: software, validation, resources.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that there is no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Beglari, M., Goudarzi, N., Shahsavani, D. et al. LM-ANN-based QSAR model for the prediction of pEC50 for a set of potent NNRTI using the mixture of ligand–receptor interaction information and drug-like indexes. Netw Model Anal Health Inform Bioinforma 9, 53 (2020). https://doi.org/10.1007/s13721-020-00259-2
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13721-020-00259-2